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ABSTRACT
Introduction A huge population in India is at high risk of 
type-2 diabetes (T2DM). Physical activity and a healthy diet 
(healthy lifestyle) improve blood glucose levels in people 
at high risk of T2DM. However, an unhealthy lifestyle is 
common among Indians. Yoga covers physical activity and 
a healthy diet and can help to prevent T2DM. The research 
question to be addressed by the main randomised 
controlled trial (RCT) is whether a Yoga programme for 
T2DM prevention (YOGA- DP) is effective in preventing 
T2DM among high risk people in India as compared with 
enhanced standard care. In this current study, we are 
determining the feasibility of undertaking the main RCT.
Intervention YOGA- DP is a structured lifestyle education 
and exercise programme. The exercise part is based on 
Yoga and includes Shithilikarana Vyayama (loosening 
exercises), Surya Namaskar (sun salutation exercises), 
Asana (Yogic poses), Pranayama (breathing practices) and 
Dhyana (meditation) and relaxation practices.
Methods and analysis This is a multicentre, two- arm, 
parallel- group, feasibility RCT with blinded outcome 
assessment and integrated mixed- methods process 
evaluation. Eligible participants should be aged 18–74 
years, at high risk of T2DM (fasting plasma glucose 
level 5.6–6.9 mmol/L) and safe to participate in physical 
activities. At least 64 participants will be randomised 
to intervention or control group with final follow- up 
at 6 months. Important parameters, needed to design 
the main RCT, will be estimated, such as SD of the 
outcome measure (fasting plasma glucose level at 
6- month follow- up), recruitment, intervention adherence, 
follow- up, potential contamination and time needed to 
conduct the study. Semistructured qualitative interviews 
will be conducted with up to 20–30 participants, a 
sample of those declining to participate, four YOGA- DP 
instructors and around eight study staff to explore their 
perceptions and experiences of taking part in the study 
and of the intervention, reasons behind non- participation, 
experiences of delivering the intervention and running the 
study, respectively.
Ethics and dissemination Ethics approval has been 
obtained from the following Research Ethics Committees: 
Faculty of Medicine and Health Sciences, University of 
Nottingham (UK); Centre for Chronic Disease Control 
(CCDC, India); Bapu Nature Cure Hospital and Yogashram 
(BNCHY, India) and Swami Vivekananda Yoga Anusandhana 
Samsthana (S- VYASA, India). The results will be widely 
disseminated among key stakeholders through various 
avenues.
Trial registration number CTRI/2019/05/018893.
INTRODUCTION
India has the world’s second- largest type-2 
diabetes (T2DM) epidemic, a disorder with 
significant health, social and economic 
consequences.1 More than 77 million Indians 
are in the high risk of T2DM category, with 
higher blood sugar levels than normal, but 
lower than the established threshold for 
Strengths and limitations of this study
 ► We are determining the feasibility of undertaking the 
main randomised controlled trial (RCT), and import-
ant parameters, needed to design the main RCT, will 
be estimated.
 ► This is a multicentre, two- arm, parallel- group, fea-
sibility RCT with blinded outcome assessment and 
integrated mixed- methods process evaluation.
 ► The study is registered with the Clinical Trials 
Registry- India, a part of the WHO Registry Network.
 ► Being a feasibility RCT, it is not adequately powered 
to detect a difference in outcomes between the two 
study arms.
 ► However, appropriate regression methods will be 
used to get initial estimates of effects with CIs to 
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T2DM itself.2 They are more likely to develop T2DM 
and its complications than people with normal blood 
glucose levels.3 Physical inactivity and an unhealthy diet 
are important risk factors of T2DM.3 Screening of people 
at high risk of T2DM, followed by an effective lifestyle 
intervention (ie, physical activity and a healthy diet) is a 
cost- effective strategy.3 It improves blood glucose levels in 
people at high risk of T2DM and has other health bene-
fits.4 5 However, physical activity levels are lower among 
Indians.6 Similarly, consumption of an unhealthy diet is 
high among Indians.7 8
Yoga, an ancient Indian mind- body discipline, covers 
not only physical activity, but also a healthy diet.9 There 
are many different styles of Yoga, focusing on the same 
core issue, that is, a healthy lifestyle. No style is necessarily 
better or more authentic than any other.10 The accept-
ability of Yoga is usually high among Indians because it 
fits their health beliefs and culture.11 12 Generally, Yoga 
uses a gentle approach, is easy to learn and safe, requires 
a low to moderate level of guidance, is inexpensive to 
maintain and can be practised indoors and outdoors.11 
It can be practised by older people or those with a wide 
range of comorbidities—it can help with arthritis and 
can prevent falls.10 11 Some of the Yogic practices are of 
low- intensity (<3.5 kcal/min) and some are of moderate- 
intensity (3.5–7.0 kcal/min).10 13 For example, the Surya 
Namaskar component of Yoga (sun salutation exercises) 
burns about 3.8–6.7 kcal/min.14 15 Yoga is also consid-
ered as a muscle- strengthening activity.10 Thus, it can 
contribute to the aim of routine lifestyle advice to prevent 
T2DM among high risk individuals.
The beneficial effects of Yoga practice on T2DM- 
related risk profiles appear to occur via two major path-
ways. First, by reducing the activation and reactivity of the 
sympathoadrenal system and the hypothalamic- pituitary- 
adrenal axis, and promoting feelings of well- being, it may 
alleviate the effects of stress and foster multiple positive 
downstream effects on neuroendocrine status, metabolic 
function and related systemic inflammatory responses. 
Second, by directly stimulating the vagus nerve, it may 
enhance parasympathetic activity and lead to positive 
changes in cardiovagal function, mood, energy state and 
in related neuroendocrine, metabolic and inflammatory 
responses. Furthermore, Yoga may lead to weight loss, 
which itself lowers the risk of T2DM.16
Systematic reviews of clinical trials suggest beneficial 
effects of Yoga on T2DM- related outcomes in T2DM (as 
adjuvant therapy) and in metabolic syndrome.17–20 One 
such systematic review of 44 randomised controlled trials 
(RCTs) analysed data from T2DM, metabolic syndrome 
and healthy participants (n=3168).17 Relative to usual 
care or no intervention, Yoga improved blood glucose 
levels (mean difference=−0.45%; 95% CI −0.87 to −0.02). 
No major safety issues were reported. However, most of 
the included studies were short- term (≤3 months) and 
were often associated with considerable methodolog-
ical limitations, such as small sample sizes in treatment 
groups, resulting in lack of statistical power for outcome 
assessment, and poor concealment of treatment alloca-
tion in outcome assessment, leading to potential analysis 
bias.
In addition, some of the relevant previous studies have 
not described the intervention in detail, making it diffi-
cult to replicate successful interventions.17–20 Most studies 
have not reported the intervention development process. 
It is hard to know whether these interventions were care-
fully thought out (eg, their safety and acceptability) and 
comprehensive in their development. Thus, it is difficult 
to select (and replicate) one successful intervention over 
another. A further selection barrier is their heterogeneous 
contents, which needed to be summarised for utilisation 
in T2DM prevention. Therefore, we addressed these 
issues by systematically developing a Yoga programme for 
T2DM prevention (YOGA- DP) among high risk people in 
India, which will be published elsewhere. Briefly, this iter-
ative process included five steps: (1) a systematic review 
of the literature to generate a list of Yogic practices that 
improves blood glucose levels among adults at high risk of 
or with T2DM, (2) validation of identified Yogic practices 
by Yoga experts, (3) development of the intervention, (4) 
consultation with a range of relevant experts about the 
intervention and (5) pretest the intervention among Yoga 
practitioners and lay people in India.
Health interventions should be informed by and 
compatible with the sociocultural expectations of people 
and their health beliefs.21 Yoga is such an intervention in 
India. The Indian government is committed to and has 
prioritised the prevention and management of chronic 
diseases like T2DM through traditional Indian therapies 
like Yoga. The Ministry of AYUSH is dedicated exclusively 
towards traditional Indian therapies.22 There is, therefore, 
a need for a definitive, robustly designed study to assess 
the utility of Yoga in T2DM prevention among high risk 
people in India. The principal research question to be 
addressed by the main RCT is whether YOGA- DP is effec-
tive in preventing T2DM among high risk people in India 
as compared with enhanced standard care. The primary 
outcome of the main RCT will be the difference in mean 
fasting plasma glucose level between the two treatment 
arms. We intend to do long- term (≥1 year) follow- ups in 
the main RCT. The chances of successful completion of 
a costly T2DM prevention RCT will improve if the feasi-
bility of its key elements is checked before it starts.23 24 
Important parameters, needed to design the main RCT, 
will be estimated.23 Thus, in this current study, we are 
determining the feasibility of undertaking the main RCT.
METHODS AND ANALYSIS
Study design
This is a multicentre, two- arm, parallel- group, feasibility 
RCT (see figure 1) with blinded outcome assessment and 
integrated mixed- methods process evaluation.
Study setting
The study is conducted at two Yoga centres in India—
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Cure Hospital and Yogashram (BNCHY, New Delhi)) 
and southern part of India (Swami Vivekananda Yoga 
Anusandhana Samsthana (S- VYASA, Bengaluru)). People 
from a range of socioeconomic backgrounds access 
the services provided by these two research- active Yoga 
centres. Three languages (English, Hindi and Kannada) 
are used to conduct the study.
Sample size estimation
Randomised controlled trial
At least 64 participants (32/group) will be adequate to 
precisely estimate the SD of the outcome measure (fasting 
plasma glucose level at 6- month follow- up). This is calcu-
lated in relation to the desired level of confidence (95%) 
for the SD, the chosen power (80%) and significance 
level (5%, two- tailed) of the analysis in the main RCT and 
the expected loss to follow- up (20% at 6 months) in the 
current study.25 26
Qualitative evaluation
 ► Participants: interviews will be conducted with 
up to 20–30 participants. Until data saturation is 
achieved, purposive sampling will be used to ensure 
the representation of diversity within the RCT 
population.27
 ► Those who decline to participate in the study: a 
sample of those who agree to be interviewed about 
their reasons for non- participation, around 10–15, 
but will continue until saturation is reached.27
 ► Four YOGA- DP instructors and around eight study 
staff (at the two sites).
Screening and recruitment strategies
A multipronged approach is used to identify potential 
participants at both sites:
 ► Advertisement through posters and pamphlets 
(placed/distributed at various locations including 
these Yoga centres, communities, religious places, 
parks and health clinics).
 ► Screening camps at various locations (including these 
Yoga centres, communities and religious places) and 
times.
 ► Door to door visits in various communities and at 
various times.
After potential participants have been given the partic-
ipant information sheet, a description of the study and 
any questions have been answered, people interested 
in the study are requested to provide written informed 
consent. Those providing written informed consent are 
assessed against the study eligibility criteria. Their fasting 
blood glucose level is determined by finger- prick using 
a glucometer. At these two sites, two glucometer brands 
are used for this purpose: HemoCue Glucose 201+ System 
and Accu- Chek Active. Those potentially at high risk of 
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T2DM (ie, fasting blood glucose level 5.6–6.9 mmol/L 
(ie, 100–125 mg/dL))28 are invited to these Yoga centres 
for a confirmatory venous blood test, using a standard-
ised method (see table 1) and after taking further written 
informed consent. They are re- assessed against the eligi-




 ► Aged 18–74 years.
 ► At high risk of T2DM.
 ► Safe to participate in physical activities (assessed 
using the Physical Activity Readiness Questionnaire 
(PAR- Q)/clinician).29
 ► Willing and able to attend the intervention/control 
sessions on their own.
 ► Able to provide written informed consent.
Exclusion criteria
 ► Pregnant women.
 ► Those with glycated haemoglobin ≥6.5% (ie, 
≥48 mmol/mol; with T2DM).28
Table 1 Data collection






Eligibility assessment   √
Socio- demographics   √
Medical and surgical history   √
Family history of diabetes     √   
Current medications     √ √
Biochemical parameters†         
  Blood glucose         
  Fasting plasma glucose Glucose oxidase- peroxidase method   √ √
  Glycated haemoglobin High- performance liquid chromatography method   √ √
  Lipid profile         
  Total cholesterol Cholesterol oxidase method   √ √
  High- density lipoprotein Direct clearance method   √ √
  Low- density lipoprotein Direct clearance method   √ √
  Very low- density lipoprotein Calculated value   √ √
  Triglyceride Lipase/Glycerol-3- phosphate oxidase- phenol+aminophenazone 
no correction method
  √ √
Physiological parameters         
  Blood pressure Omron HEM-7201   √ √
  Heart rate Omron HEM-7201   √ √
Anthropometric parameters         
  Waist circumference Seca 201 (measuring tape)   √ √
  Weight Omron HN-286 (weighing scale)   √ √
  Height Seca 206 (stadiometer)   √ √
  Body mass index Calculated value   √ √
Diet Time- recall: past 1 week √ √
Physical activity International Physical Activity Questionnaire—short; time- recall: 
past 1 week33
  √ √
Tobacco usage     √ √
Alcohol consumption     √ √
Health- related quality- of- life EuroQol- 5D- 5L; time- recall: at the time of questionnaire 
completion34
√ √
Depression, anxiety and stress Depression, Anxiety and Stress Scale; time recall: past 1 week35   √ √
Yoga practice Time- recall: past 1 week   √ √
Self- efficacy (to assess confidence in 
participant’s ability to practise Yoga)
0–100 rating scale; time- recall: at the time of questionnaire 
completion36
  √ √
*A standard operating procedure has been developed for this purpose.









pen: first published as 10.1136/bmjopen-2019-036277 on 6 September 2020. Downloaded from 
5Chattopadhyay K, et al. BMJ Open 2020;10:e036277. doi:10.1136/bmjopen-2019-036277
Open access
 ► Those with any serious or uncontrolled medical 
condition (eg, cancer).
 ► Those who regularly practice Yoga, that is, ≥150 min/
week.
 ► Those currently receiving (or with plans to 
receive during the study period) any related 
non- pharmaceutical/pharmaceutical research 
intervention.
Randomisation
Eligible participants are randomised to intervention or 
control group according to a computer- generated rando-
misation schedule (1:1, block randomisation, stratified by 
sex and site), done centrally by an independent statisti-
cian at the Centre for Chronic Disease Control (CCDC), 
New Delhi, India. This is accessed by calling a telephone 
line. The exception to this rule is individuals recruited 
from the same household or if they are close relatives 
or friends, who are randomised to the same group to 
avoid contamination. After randomisation, key baseline 
data are collected. Participants and intervention/control 
providers cannot be ‘blinded’ to group allocation, but the 
outcome assessors are ‘blind’.
Interventions
Intervention (YOGA-DP)
YOGA- DP is a structured lifestyle education and exer-
cise programme, provided over a period of 24 weeks 
(see table 2). The exercise part is based on Yoga and 
includes Shithilikarana Vyayama (loosening exercises), 
Surya Namaskar (sun salutation exercises), Asana (Yogic 
poses), Pranayama (breathing practices) and Dhyana 
(meditation) and relaxation practices. Online supple-
mentary table S1 shows the structure and content of the 
Yoga sessions. The programme is delivered by YOGA- DP 
instructors—qualified and experienced Yoga teachers 
with formal training provided on the intervention. 
Female instructors are available for female participants. 
Group Yoga sessions are run locally (such as at these Yoga 
centres and community centres) at different time points 
of the day (with evening and weekend sessions), and 
participants can join as per their convenience. We are 
reimbursing some of their local travel costs for attending 
the sessions. A family member or someone close to the 
participant is invited to join them in the sessions. Once 
participants complete the programme, they are strongly 
encouraged to maintain a healthy lifestyle in the long- 
term, using the intervention booklet and a video.
Intervention fidelity will be ensured through regular 
training of YOGA- DP instructors, based on the manual 
developed for them. Also, sessions will be regularly 
observed and assessed with a checklist to ensure that 
they are being delivered as per the manual. To improve 
performance, structured and instructive feedback will be 
provided.
Control (enhanced standard care)
Currently, no standard lifestyle intervention is available 
in India for people at high risk of T2DM. Control group 
participants will receive a leaflet on routine lifestyle 
advice to prevent T2DM among high risk individuals. 
Table 2 Structure of YOGA- DP
Week
Group Yoga sessions delivered 
by YOGA- DP instructors
Self- practice of Yoga at home using 
YOGA- DP booklet and a video Extra features
1–4
(month 1)
At least two sessions of 45 min 
per week. An attendance register 
is kept.
– At the first session, the instructor is giving 
participants part one of our programme 
booklet. This gives them information 
about being at high risk of T2DM and 
how to prevent T2DM (ie, by being more 
physically active, keeping a healthy weight, 
eating less fat (especially saturated fat) 
and eating more fibre).
5–12
(month 2–3)
At least two sessions of 75 min 
per week. An attendance register 
is kept.
– At the last session, the instructor is giving 
participants part two of our programme 
booklet and a video. These give them 
information on Yoga practice to prevent 
T2DM. Also, a Yoga diary and non- slippery 




At least one session of 75 min 
every 4 weeks. An attendance 
register is kept.
At least two sessions of 75 min per 
week. Participants are given the Yoga 
diary to record their Yoga practice 
(types and minutes).
The instructor is phoning participants 
every week to offer support and help and 
to troubleshoot any problems.
25+
(month 7+)
– At least two sessions of 75 min per 
week. Participants are given the Yoga 
diary to record their Yoga practice 
(types and minutes).
–
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This is delivered by a different team member (ie, not by 
the YOGA- DP instructor) to avoid contamination. This 
provision would ensure that control group participants 
feel that there are benefits to participation (hence, lower 
attrition). Contamination could occur in the control 
group if they start practising Yoga during follow- up. 
However, the specific intervention (YOGA- DP) is not 
available externally, even if Yoga classes are.
Study parameters and data collection
Randomised controlled trial
 ► SD of the outcome measure (mentioned before), 
which will be used to calculate the main RCT sample 
size.
 ► Recruitment—number of people approached to 
participate, written informed consent given, screened 
for eligibility, found eligible and randomised.
 ► Intervention adherence—number of sessions 
attended out of the 27 sessions, number who self- 
practice at home and frequency and duration of self- 
practice at home.
 ► Follow- up—number of randomised participants 
followed- up at 6 months.
 ► Potential contamination—number of control group 
participants participating in any Yoga class during 
6- month follow- up (self- reported).
 ► Time needed to conduct the study (eg, to recruit 
participants).
 ► See table 1.
Qualitative evaluation
 ► Participants: interviews will be conducted with them to 
explore their perceptions and experiences of taking 
part in the study (intervention and control group 
participants who complete or do not complete the 
study) and of the intervention (intervention group 
participants who complete or do not complete the 
intervention).
 ► Those who decline to participate in the study: they 
are requested to complete a questionnaire (including 
reasons behind non- participation), and a sample of 
those who agree to be interviewed to further explore 
these reasons.
 ► YOGA- DP instructors and study staff (at the two sites): 
interviews will be conducted with them to explore 
their experiences of delivering the intervention and 
running the study, respectively.
Predeveloped interview guides will be used by a quali-
tative researcher to conduct these semistructured inter-
views. The interviews will be conducted in interviewees’ 
preferred language and with the help of an interpreter 




Baseline characteristics and important parameters such as 
follow- up will be summarised and compared between the 
two study arms using numbers and percentages for cate-
gorical data and summary measures of mean or median 
and spread for continuous data. Being a feasibility RCT, 
it is not adequately powered to detect a difference in 
outcomes between the two study arms. However, appro-
priate regression methods will be used to get initial esti-
mates of effects with CIs to guide the design of the main 
RCT. All primary analyses will be based on the intention- 
to- treat principle and will be unadjusted. Subsequently, 
the adjustment will be done for the baseline data and site. 
No interim analysis is planned.
Qualitative evaluation
All the semistructured interviews will be transcribed 
(verbatim), translated (if necessary), anonymised and 
checked for accuracy. An interpretive analysis will be 
conducted using thematic analysis, using NVivo soft-
ware. Transcripts will be read and re- read by two qual-
itative researchers. These researchers will develop 
the initial codes and will apply initially to a small 
number of transcripts, enabling further iteration of the 
thematic index. We will use illustrative non- attributable 
quotations.27
Patient and public involvement
The research topic was identified and discussed with a 
Public Engagement Coordinator and among a patient 
and public involvement group. They acknowledged the 
importance of this research topic and the issues identi-
fied during these discussions were taken into consider-
ation while designing the study. They are involved in the 
discussions and are giving feedback on different aspects 
of the study.
ETHICS AND DISSEMINATION
Ethics and other related issues
Ethics approval has been obtained from the following 
Research Ethics Committees: Faculty of Medicine 
and Health Sciences, University of Nottingham, UK 
(14-1805); CCDC, India (CCDC_IEC_09_2018); 
BNCHY, India (BNCHY/IEC/2/2019) and S- VYASA, 
India (RES/IEC- SVYASA/138/2018). Written informed 
consent is obtained from all the participants. We have 
also received approval from the Health Ministry’s 
Screening Committee (HMSC, India). An independent 
Trial Steering Committee is monitoring and providing 
overall supervision for the study.
Serious adverse events
Like other physical activities, Yoga is known to be safe.10 
Information will be collected on serious adverse events 
(including death) occurring in participants that may 
be attributed to the interventions. Based on medical 
and scientific judgement, an independent clinician 
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Participant withdrawal
Participants will be withdrawn from the study either at 
their request or at the discretion of the site investigator 
for example, if diagnosed with diabetes (will receive 
the standard treatment) or if no longer safe to partici-
pate in physical activities (determined by PAR- Q/clini-
cian).29 They will be made aware that this will not affect 
their future care. Also, they will be made aware (via the 
participant information sheet and consent form) that 
should they withdraw, the data collected to date will not 
be erased and may still be used in the final analyses.
Dissemination
The results will be reported according to the relevant 
extension of the Consolidated Standards of Reporting 
Trials statement, that is, for randomised pilot and feasi-
bility trials.30 The results will be widely disseminated 
among key stakeholders through various avenues, such as 
through dissemination meetings and informal discussions 
with them, presentations at national and international 
conferences, publications in peer- reviewed open- access 
journals and press offices and websites of host institutions.
DISCUSSION
We are now conducting a multicentre feasibility RCT in 
India to determine the feasibility of undertaking the main 
RCT. The study started in May 2019, and we are aiming to 
finish the study by the end of October 2020. If the feasi-
bility is promising (such as recruitment, randomisation, 
intervention adherence and follow- up), then the param-
eters estimated will be used to design the main RCT. 
Decisions over whether to modify the protocol will be 
informed by the process evaluation, including the qual-
itative data.
If the intervention is found to be effective in the main 
RCT, it will be a low- cost, acceptable and local solu-
tion to prevent T2DM among high risk people in India 
and to become healthier overall. The future clinical, 
personal and economic burden of T2DM on patients, 
their families, the health system and the economy will 
be prevented. The benefits of preventing T2DM may 
extend to the prevention of its complications. People 
will be provided with more evidence- based choices 
for preventing T2DM. The programme will simulta-
neously empower them to manage their health. Apart 
from India and neighbouring South Asian countries, 
Yoga is popular or becoming popular in many other 
countries.31 32 Given that T2DM prevention is a global 
concern and costs are a concern everywhere, a low- cost 
Yoga- based T2DM prevention option will be of interest 
in other countries, particularly in other South Asian 
countries and in countries with South Asian ethnic 
minorities.
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